This course is designed for undergraduate students who are enrolled at a US-based two- or four-year college or university and have completed at least one year of study. Learn more about the flexible format and levels of engagement below!
More information about the 2025 iteration of this course will be available in March 2025.
This virtual short course is intended for undergraduates who are interested in exploring the field of cancer genomics and learning the impact of genomics on cancer diagnosis and treatment. With a variety of topics covered, including cancer cell biology, genomic research, variant curation, human subjects research, personalized medicine, and cancer disparities, you will gain a comprehensive picture of cancer genomics during this course.
During one-hour, live sessions held on Zoom, you will learn how to interpret cancer genomics data and engage with cancer researchers and other professionals working in the field of cancer genomics. Students can opt to interact with peers virtually through course discussion boards, and students who want to engage on an even deeper level can complete an inquiry project. Through this project, students will apply their knowledge of cancer genomics and will work in groups to navigate online cancer genomics databases, determine variant clinical significance, and decide on the best path of treatment for a fictional patient.
Participants will be able to apply knowledge gained in this course to:
This course is completely free and is open to undergraduate students who are enrolled at any US-based two- or four-year college or university and have completed at least one year of study.
The course offers flexibility with three tiers of engagement. View the table below to determine which Tier to register for.
Tier | Time Commitment | What You'll Do | What You'll Get | Registration Deadline |
I | 6 hours |
|
|
July 1, 2024 11:59 p.m. ET |
II | 10 hours |
|
|
May 31, 2024 11:59 pm ET |
III | 15 – 20 hours |
|
|
May 31, 2024 11:59 pm ET |
“The most memorable part of the course was the opportunity to listen to the insightful and knowledgeable guest speakers. Their expertise and diverse perspectives provided valuable insights into various aspects of cancer biology, making the learning experience both enriching and enjoyable.”
“I found the course content to be truly fascinating. It helped me expand my understanding and knowledge of cancer and the cellular mechanisms involved.”
“I really enjoyed putting together the patient report and doing the research for the checkpoints because it allowed me to learn more about how different genes work and how variants can affect their function, as well as looking into the types of treatments and making a clinical recommendation.”
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.